September

September 30, 2014

Natural product-based therapy for Cancer: Berberine inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 30/September/2014, 12.38 pm

The 1989 Nobel prize winner in Physiology/Medicine Prof. Varmus Harold E, Somwar R and others from High Throughput Screening Core Facility, and Organic Synthesis Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; and US […]
September 30, 2014

Addressing Nobel laureate Bishop JM’s conundrum (c-MYC suppresses cancer metastasis): Does p53 function as a metastasis promoter in certain cellular contexts by increasing the expression of αv and β3 integrin subunits?, 30/September/2014, 9.17 am

The 1989 Nobel prize winner in Physiology/Medicine, Prof. Bishop JM, Liu H and others from G.W. Hooper Foundation, University of California at San Francisco, San Francisco, California 94143, USA has published a research paper in […]
September 30, 2014

Molecular therapy for Human Cancer: MyoD suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 30/September/2014, 8.17 am

The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.”  This study […]
September 30, 2014

MiRNA-based cancer therapeutics: MiRNA-141 increases the expression of tumor suppressor p53 and its homolouge p73 via down regulation of its target gene, 30/September/2014, 08.00 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based cancer therapeutics: MiRNA-141 increases the expression of tumor suppressor p53 and its homolouge p73 via down […]